Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10201264 | 0.77 | AGXT (0.39) | SLC6A4 | |
| SCHEMBL18347157 | 0.77 | TAAR1 (0.50) | — | |
| SCHEMBL15802699 | 0.77 | EPHX1 (0.56) | SLC6A4EPHX1 | |
| SCHEMBL17264165 | 0.73 | CSK (0.50) | SLC6A4 | |
| SCHEMBL14666766 | 0.72 | NQO1 (0.45) | — | |
| SCHEMBL14666765 | 0.72 | ITGB3 (0.35) | SLC6A4 | |
| SCHEMBL21350258 | 0.71 | PTPN1 (0.35) | SLC6A4 | |
| SCHEMBL12015202 | 0.69 | SLC7A5 (0.62) | — | |
| SCHEMBL12015201 | 0.69 | SLC7A5 (0.62) | — | |
| SCHEMBL12238380 | 0.69 | HTR2A (0.56) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120220649-A1 | MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220649-A1 | MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE | POLM, POLN, PNKP | SLC6A4 1276/4885EPHX1 4713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.